Epidemiological Analysis of Hospitalized Children with Acute Asthma Exacerbation over 30 Years.

Publication date: May 29, 2026

To provide an evidence-based reference for preventing and managing pediatric acute asthma exacerbations by examining epidemiology and long-term trends of hospitalized cases in a tertiary hospital in Beijing over 30 years. Retrospective analysis of clinical data from children hospitalized for acute asthma exacerbation at Peking University Third Hospital from 1994 to 2023. Data collected included demographics, onset timing, and hospital stay duration, with distribution patterns analyzed across ages, years, seasons, and months. The study included 1106 patients (65. 73% male, 34. 27% female) with a median age of 4 years. Hospitalizations peaked in 1999 (8. 40%) and declined, reaching the lowest point in 2020 (1. 45%) coinciding with the COVID-19 pandemic. Most admissions occurred in autumn (34. 27%), especially in October (13. 29%). The average hospital stay was 5. 35 +/- 2. 65 days, longest for toddlers. Over 30 years, pediatric hospitalizations for acute asthma exacerbations in this tertiary center have shown a declining trend, suggesting improved asthma management. However, the persistent autumn peak and male predominance highlight the need for targeted prevention strategies-particularly for male and preschool-aged children before the autumn school term-to further reduce acute exacerbations and hospitalizations.

Open Access PDF

Concepts Keywords
Autumn Acute Disease
Beijing Adolescent
Female allergy
Hospitalizations Asthma
Pandemic asthma exacerbation
Beijing
Child
Child, Preschool
children
COVID-19
Disease Progression
epidemiology
Female
Hospitalization
Humans
Infant
Length of Stay
Male
Retrospective Studies
Seasons

Semantics

Type Source Name
disease MESH Asthma
pathway KEGG Asthma
disease MESH included
disease MESH COVID-19 pandemic
disease MESH pku
disease MESH allergy
disease MESH infection
disease MESH viral infections
drug DRUGBANK Medical air
drug DRUGBANK Methionine
disease MESH respiratory system diseases
disease MESH foreign bodies
disease MESH tumors
disease MESH trauma
disease MESH hos
drug DRUGBANK Coenzyme M
drug DRUGBANK Lysergic acid diethylamide
disease MESH cross infections
disease MESH respiratory tract infections
disease MESH wheezing
disease MESH fac
disease MESH influenza
pathway REACTOME Translation
drug DRUGBANK Etoperidone
disease MESH emergency
disease MESH Dis
disease MESH Lam
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Sulfasalazine
disease MESH Respiratory syncytial virus infection
drug DRUGBANK Vorinostat
drug DRUGBANK Diphenylpyraline
disease MESH inflammation
drug DRUGBANK L-Tryptophan
disease MESH Acute Disease
disease MESH Disease Progression

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *